跳至主要内容
临床试验/IRCT20230822059222N2
IRCT20230822059222N2已完成2 期

A Randomized Clinical Trial to Evaluate the Efficacy of Systemic Treatment in Combination with Topical Tacrolimus versus Systemic Treatment Alone in Managing Skin Involvement of Patients with Idiopathic Granulomatous Mastitis

Shiraz University of Medical Sciences0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
Female

入选标准

  • A confirmed diagnosis of idiopathic granulomatous mastitis (IGM) based on histopathological examination
  • The severity of involvement should be grade II, III, or IV according to the modified classification of Yuan et al
  • consent to participate in the study

排除标准

  • breast carcinoma or other malignancies
  • require surgical treatment
  • systemic diseases such as vasculitis, collagen vascular disease, or sarcoidosis
  • a risk factor for steroid therapy, such as hypertension or diabetes mellitus

研究者

相似试验